| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.12▼ | 4.12▼ | 4.12▼ | 4.10▼ | 4.20▼ |
| MA10 | 4.25▼ | 4.25▼ | 4.25▼ | 4.21▼ | 4.15▼ |
| MA20 | 4.31▼ | 4.31▼ | 4.28▼ | 4.21▼ | 4.10▲ |
| MA50 | 4.18▼ | 4.18▼ | 4.18▼ | 4.10▼ | N/A |
| MA100 | 4.02▼ | 3.91▲ | 3.89▲ | 4.07▲ | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | 37.034▼ | N/A | N/A | N/A | N/A |
| STOCH | 2.857▼ | 19.718▼ | 19.718▼ | 16.729▼ | 61.583 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -78.992▼ | -51.724 |
| CCI | -129.782▼ | -109.926▼ | -109.926▼ | -104.139▼ | -23.834 |
|
Thursday, October 31, 2019 04:25 AM
MARINA DEL REY, Calif., Oct. 31, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage ...
|
|
Wednesday, October 16, 2019 04:24 AM
MARINA DEL REY, Calif., Oct. 16, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage ...
|
|
Thursday, August 29, 2019 01:22 PM
He previously worked as director at Armata Pharmaceuticals (NYSE: ARMP) and president and CEO of Aviragen Therapeutics, according to the release. He said there are no plans to relocate the firm.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/12/19 | 4.03 | 4.10 | 4.0297 | 4.10 | 9,374 |
| 09/12/19 | 4.03 | 4.03 | 3.975 | 3.99 | 23,615 |
| 06/12/19 | 4.1579 | 4.1579 | 4.00 | 4.03 | 18,050 |
| 05/12/19 | 4.23 | 4.27 | 4.13 | 4.14 | 7,527 |
| 04/12/19 | 4.28 | 4.38 | 4.23 | 4.26 | 11,000 |
| 03/12/19 | 4.21 | 4.32 | 4.21 | 4.32 | 6,600 |
| 02/12/19 | 4.45 | 4.47 | 4.22 | 4.23 | 13,900 |
| 29/11/19 | 4.38 | 4.57 | 4.3005 | 4.38 | 15,069 |
| 27/11/19 | 4.32 | 4.39 | 4.30 | 4.38 | 11,200 |
| 26/11/19 | 4.29 | 4.54 | 4.17 | 4.30 | 29,100 |
|
|
||||
|
|
||||
|
|